Global Sterile Injectable Drugs Market: Snapshot

The global sterile injectable drugs market is prophesied to achieve growth on the back of short timelines for approval of new drugs to be used in the treatment of chronic diseases such as cancer. The Food and Drug Administration (FDA) in the U.S. is observed to approve sterile injectable drugs at a faster rate. While this could provide a good boost to the market, other factors such as snowballing focus on the research and development of anti-cancer drugs and increasing number of chronic and cardiovascular diseases are anticipated to set the tone for a valuable growth in the near future.

The global sterile injectable drugs market is expected to expand at a CAGR of 11.1% between 2017 and 2025 to secure a valuation of US$901.3 bn by the completion of the forecast tenure. In 2017, the market accomplished a valuation of US$387.1 bn.

global sterile injectable drugs market

Monoclonal Antibodies Boasting of Monovalent Affinity Clutch Dominating Share

The world sterile injectable drugs market could be segmented as per geography, distribution channel, indication, drug class, and type. In terms of type, the market could see a classification into large molecule and small molecule. Amongst these, large molecule is projected to achieve a higher growth in the coming years.

On the basis of class of drug, there could be segments such as peptide antibiotics, blood factors, immunoglobulins, vaccine, peptide hormones, insulin, cytokines, and monoclonal antibodies (mAbs) offering growth in the world sterile injectable drugs market. Out of these, mAbs are predicted to exhibit a stronger growth in the foreseeable future. Forecast to be followed by the segments of insulin and vaccines, mAbs accounted for an over 26.0% share in 2016. The ability to bind to the same epitope with the help of monovalent affinity could be an exclusive feature of mAbs supporting the segment to secure a larger share in the market. Furthermore, mAbs could carry drugs and help to trigger the immune system.

With respect to indication, the world sterile injectable drugs market could be segmented into infectious diseases, pain, hematology, gastroenterology, autoimmune, oncology, neurology, and cardiology and metabolic disorders. By distribution channel, the market is envisaged to be cataloged into ecommerce, retail pharmacy, and hospital pharmacy.

North America Banks on Extensive Research and Development for Global Lead

Regionally, it could be said that North America and Europe dominated the international sterile injectable drugs market in 2016 with a sizable aggregate share. However, North America took the lead in the market during the year, and is prognosticated to continue to gain traction in the coming years. With an 89.1% share bagged in 2016, the U.S. outplayed other countries in the region while riding on comprehensive research and development, technological advancements, and the rising need to manage and treat chronic diseases.

Treading on the heels of North America and Europe, Asia Pacific (APAC) is envisioned to showcase a faster growth in the international sterile injectable drugs market, mainly on the back of countries such as China, Japan, and India. Some of the factors that could augment market growth in APAC are rising awareness, high count of patients, promising policies, and new product launches. In Latin America, Brazil could secure a good share of the international market while riding on continuous investments in healthcare infrastructure and recent economic development.

The worldwide sterile injectable drugs market could include leading companies such as Science, Inc., Gilead, AstraZeneca, GlaxoSmithKline plc, and Pfizer Inc.

Escalating Number of Cancer Cases to Boost the Growth Prospects of the Sterile Injectable Drugs Market

The sterile injectable drugs market is estimated to gain a substantial growth-share during the assessment period of 2017-2025 on the back of the rising availability of treatment options and the growing cancer prevalence around the world. The World Health Organization (WHO) stated that cancer is one of the leading causes of death around the globe. These statistics signal the rising need for controlling the deaths caused due to cancer. All these aspects bring tremendous growth opportunities for the sterile injectable drugs market.

  • Sterile injectable drugs have the same ingredients as their branded versions and can be referred to as biologics used for the treatment of various drugs. These aspects bring good growth opportunities. The growing need for the treatment of non-communicable diseases among a large chunk of the global populace will bring promising opportunities.
  • Research and development activities are serving as prominent growth generators. These activities help in discovering new insights. The players are investing hefty amounts in the research and development activities related to the sterile injectable drugs market. The players use these activities for formulating new formulations and further increasing their revenues. All these aspects play a major role in increasing the growth rate.
  • Strategic collaborations help in boosting the growth prospects of the sterile injectable drugs market. The players indulge in mergers, acquisitions, partnerships, and joint ventures. The players strengthen their foothold through these collaborations and further help in increasing the growth opportunities across the sterile injectable drugs market.
  • The COVID-19 pandemic has not impacted the sterile injectable drugs market to a substantial extent. The sterile injectable drugs market was exempted from the lockdown restrictions as it comes under the healthcare and pharmaceuticals category. However, supply chain and logistics disruptions during the strict lockdown had a minimal negative effect on the growth.

This report on sterile injectable drugs market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing sterile injectable drugs products as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global sterile injectable drugs market with respect to the leading market segments based on major types, applications, usage, end users, and geographies.

Based on the product type, the sterile injectable drugs market has been segmented into: small and large molecules. In term of indication, it can be segmented into cardiology & metabolic disorders, neurology, oncology, autoimmune, gastroenterology, hematology, pain, infectious diseases and others. On the basis of drug class it can be segmented into monoclonal antibodies, cytokines, peptide hormones, vaccines, peptide antibiotics, insulin, blood factors, immunoglobulin and others,. Each of the market segments have been extensively analyzed based on the market related factors such as increasing adoption rate worldwide, technological advancement, and growing number of use of disposable products in various geographies. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the sterile injectable drugs market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global sterile injectable drugs market.

Geographically, sterile injectable drugs market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, market strategy overview, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global sterile injectable drugs market.

The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global sterile injectable drugs market. The report also profiles key players operating in the sterile injectable drugs market which are Baxter International Inc., Sanofi, Pfizer Inc., and GlaxoSmithKline plc. AstraZeneca, Gilead, Sciences, Inc., Merck & Co., Inc., Novartis AG, Johnson & Johnson Services, Inc., and Novo Nordisk A/S. The global sterile injectable drugs market is dominated by two global vendors that accounts for around 80% share of the global market.

The global sterile injectable drugs market is segmented as follows:

Type

  • Small Molecule
  • Large Molecule

Drug Class

  • Monoclonal Antibodies (Mabs)
  • Cytokines
  • Insulin
  • Peptide Hormones
  • Vaccine
  • Immunoglobulins
  • Blood Factors
  • Peptide Antibiotics
  • Others

Indication

  • Cardiology & Metabolic disorders
  • Neurology
  • Oncology
  • Autoimmune
  • Gastroenterology
  • Hematology
  • Pain
  • Infectious diseases
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • E-commerce

Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of the Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Israel
    • Rest of Middle East & Africa

1. Preface
     1.1. Report Scope & Market Segmentation
     1.2. Preface
     1.3. Research Highlights

2. Assumptions and Research Methodology
     2.1. Assumptions
     2.2. Acronyms Used
     2.3. Research Methodology

3. Executive Summary

4. Market Overview
     4.1. Product Overview
     4.2. Key Industry Developments
     4.3. Sterile Injectable Drugs Market Size (US$ Bn) Forecast
     4.4. Market Opportunity Map
     4.5. Porter’s Analysis 
     4.6. Sterile Injectable Drugs Market Outlook

5. Market Dynamics
     5.1. Drivers and Restraints Snapshot Analysis
     5.2. Drivers
     5.3. Restraints
     5.4. Opportunities
     5.5. Regulatory Scenario
     5.6. Pipeline Analysis
     5.7. Merger Acquisitions & Collaborations
     5.8. Brand Analysis 
     5.9. Top 3 Players

6. Global Sterile injectable Drugs Market Analysis By Type
     6.1. Key Findings
     6.2. Introduction
     6.3. Global Sterile Injectable Drugs Market Value Share Analysis, By Type
     6.4. Sterile Injectable Drugs Market Forecast By Type 
     6.5. Sterile Injectable Drugs Market Analysis, by Type
     6.6. Sterile Injectable Drugs Market Attractiveness Analysis, by Type

7. Sterile Injectable Drugs Market Analysis, By Drug Class 
     7.1. Key Findings
     7.2. Introduction
     7.3. Sterile Injectable Drugs Market Value Share Analysis, By Drug Class 
     7.4. Sterile Injectable Drugs Market Forecast, By Drug Class 
     7.5. Sterile Injectable Drugs Market Analysis, By Drug Class 
     7.6. Sterile Injectable Drugs Market Attractiveness Analysis, By Drug Class 

8. Sterile Injectable Drugs Market Analysis, by Indication 
     8.1. Key Findings
     8.2. Introduction
     8.3. Sterile Injectable Drugs Market Value Share Analysis, by Indication 
     8.4. Sterile Injectable Drugs Market Forecast, by Indication 
     8.5. Sterile Injectable Drugs Market Analysis, by Indication 
     8.6. Sterile Injectable Drugs Market Attractiveness Analysis, by Indication 

9. Sterile Injectable Drugs Market Analysis, By Distribution Channel
     9.1. Key Findings
     9.2. Introduction
     9.3. Sterile Injectable Drugs Market Value Share Analysis, By Distribution Channel
     9.4. Sterile Injectable Drugs Market Forecast, By Distribution Channel
     9.5. Sterile Injectable Drugs Market Analysis, By Distribution Channel
     9.6. Sterile Injectable Drugs Market Attractiveness Analysis, By Distribution Channel

10. Sterile Injectable Drugs Market Analysis, by Region
     10.1. Global Regulatory Scenario
     10.2. Sterile Injectable Drugs Market Value Share Analysis, By Region Type
     10.3. Sterile Injectable Drugs Market Forecast, By Region Type
     10.4. Sterile Injectable Drugs Market Attractiveness Analysis, By Region Type

11. North America Sterile Injectable Drugs Market Analysis
     11.1. Key Findings
     11.2. North America Sterile Injectable Drugs  Market Overview
     11.3. North America Sterile Injectable Drugs Market Value Share Analysis, by Country
     11.4. North America Sterile Injectable Drugs  Market Forecast, by Country
     11.5. North America Sterile Injectable Drugs Market Value Share Analysis, By Type
     11.6. North America Sterile Injectable Drugs Market Forecast By Type
     11.7. North America Sterile Injectable Drugs Market Value Share Analysis, By Drug Class
     11.8. North America Sterile Injectable Drugs Market Forecast By Drug Class 
     11.9. North America Sterile Injectable Drugs Market Value Share Analysis, By Indication
     11.10. North America Sterile Injectable Drugs Market Forecast By Indication 
     11.11. North America Sterile Injectable Drugs Market Value Share Analysis, By Distribution Channel 
     11.12. North America Sterile Injectable Drugs Market Forecast By Distribution Channel
     11.13. North America Market Attractiveness Analysis
     11.14. Market Trends

12. Europe Sterile Injectable Drugs Market Analysis
     12.1. Key Findings
     12.2. Europe Sterile Injectable Drugs  Market Overview
     12.3. Europe Sterile Injectable Drugs Market Value Share Analysis, by Country
     12.4. Europe Sterile Injectable Drugs  Market Forecast, by Country
     12.5. Europe Sterile Injectable Drugs Market Value Share Analysis, By Type
     12.6. Europe Sterile Injectable Drugs Market Forecast By Type
     12.7. Europe Sterile Injectable Drugs Market Value Share Analysis, By Drug Class
     12.8. Europe  Sterile Injectable Drugs Market Forecast By Drug Class 
     12.9. Europe Sterile Injectable Drugs Market Value Share Analysis, By Indication
     12.10. Europe Sterile Injectable Drugs Market Forecast By Indication 
     12.11. Europe Sterile Injectable Drugs Market Value Share Analysis, By Distribution Channel 
     12.12. Europe Sterile Injectable Drugs Market Forecast By Distribution Channel
     12.13. Europe Market Attractiveness Analysis
     12.14. Market Trends

13. Asia Pacific Sterile Injectable Drugs Market Analysis
     13.1. Key Findings
     13.2. Asia Pacific Sterile Injectable Drugs  Market Overview
     13.3. Asia Pacific Sterile Injectable Drugs Market Value Share Analysis, by Country
     13.4. Asia Pacific Sterile Injectable Drugs  Market Forecast, by Country
     13.5. Asia Pacific Sterile Injectable Drugs Market Value Share Analysis, By Type
     13.6. Asia Pacific Sterile Injectable Drugs Market Forecast By Type
     13.7. Asia Pacific Sterile Injectable Drugs Market Value Share Analysis, By Drug Class
     13.8. Asia Pacific  Sterile Injectable Drugs Market Forecast By Drug Class 
     13.9. Asia Pacific Sterile Injectable Drugs Market Value Share Analysis, By Indication
     13.10. Asia Pacific Sterile Injectable Drugs Market Forecast By Indication 
     13.11. Asia Pacific Sterile Injectable Drugs Market Value Share Analysis, By Distribution Channel 
     13.12. Asia Pacific Sterile Injectable Drugs Market Forecast By Distribution Channel
     13.13. Asia Pacific Market Attractiveness Analysis
     13.14. Market Trends

14. Latin America Sterile Injectable Drugs Market Analysis
     14.1. Key Findings
     14.2. Latin America Sterile Injectable Drugs  Market Overview
     14.3. Latin America  Sterile Injectable Drugs Market Value Share Analysis, by Country
     14.4. Latin America  Sterile Injectable Drugs  Market Forecast, by Country
     14.5. Latin America Sterile Injectable Drugs Market Value Share Analysis, By Type
     14.6. Latin America Sterile Injectable Drugs Market Forecast By Type
     14.7. Latin America Sterile Injectable Drugs Market Value Share Analysis, By Drug Class
     14.8. Latin America Sterile Injectable Drugs Market Forecast By Drug Class 
     14.9. Latin America Sterile Injectable Drugs Market Value Share Analysis, By Indication
     14.10. Latin America Sterile Injectable Drugs Market Forecast By Indication 
     14.11. Latin America Sterile Injectable Drugs Market Value Share Analysis, By Distribution Channel 
     14.12. Latin America Sterile Injectable Drugs Market Forecast By Distribution Channel
     14.13. Latin America Market Attractiveness Analysis
     14.14. Market Trends

15. Middle East & Africa Sterile Injectable Drugs Market Analysis
     15.1. Key Findings
     15.2. Middle East & Africa Sterile Injectable Drugs  Market Overview
     15.3. Middle East & Africa Sterile Injectable Drugs Market Value Share Analysis, by Country
     15.4. Middle East & Africa Sterile Injectable Drugs  Market Forecast, by Country
     15.5. Middle East & Africa Sterile Injectable Drugs Market Value Share Analysis, By Type
     15.6. Middle East & Africa Sterile Injectable Drugs Market Forecast By Type
     15.7. Middle East & Africa Sterile Injectable Drugs Market Value Share Analysis, By Drug Class
     15.8. Middle East & Africa  Sterile Injectable Drugs Market Forecast By Drug Class 
     15.9. Middle East & Africa  Sterile Injectable Drugs Market Value Share Analysis, By Indication
     15.10. Middle East & Africa  Sterile Injectable Drugs Market Forecast By Indication 
     15.11. Middle East & Africa  Sterile Injectable Drugs Market Value Share Analysis, By Distribution Channel 
     15.12. Middle East & Africa  Sterile Injectable Drugs Market Forecast By Distribution Channel
     15.13. Middle East & Africa  Market Attractiveness Analysis
     15.14. Market Trends

16. Competition Landscape
     16.1. Competition Matrix 
     16.2. Sterile Injectable Drugs Market Share Analysis, by Company, 2016 (Estimated)
     16.3. Company Profile
     16.4. Baxter International 
             16.4.1. Company Details
             16.4.2. Business Overview
             16.4.3. Financial Overview
             16.4.4. Strategic Overview
             16.4.5. SWOT Analysis
     16.5. Sanofi S.A.
             16.5.1. Company Details
             16.5.2. Business Overview
             16.5.3. Financial Overview
             16.5.4. Strategic Overview
             16.5.5. SWOT Analysis
     16.6.  Pfizer, Inc. 
             16.6.1. Company Details
             16.6.2. Business Overview
             16.6.3. Financial Overview
             16.6.4. Strategic Overview
             16.6.5. SWOT Analysis
     16.7. GlaxoSmithKline Plc. 
             16.7.1. Company Details
             16.7.2. Business Overview
             16.7.3. Financial Overview
             16.7.4. Strategic Overview
             16.7.5. SWOT Analysis
     16.8. AstraZeneca 
             16.8.1. Company Details
             16.8.2. Business Overview
             16.8.3. Financial Overview
             16.8.4. Strategic Overview
             16.8.5. SWOT Analysis
     16.9. Merck & Co., Inc. 
             16.9.1. Company Details
             16.9.2. Business Overview
             16.9.3. Financial Overview
             16.9.4. Strategic Overview
             16.9.5. SWOT Analysis
     16.10. Novartis AG 
             16.10.1. Company Details
             16.10.2. Business Overview
             16.10.3. Financial Overview
             16.10.4. Strategic Overview
             16.10.5. SWOT Analysis
     16.11. Johnson & Johnson Services, Inc. 
             16.11.1. Company Details
             16.11.2. Business Overview
             16.11.3. Financial Overview
             16.11.4. Strategic Overview
             16.11.5. SWOT Analysis
     16.12. Novo Nordisk A/S 
             16.12.1. Company Details
             16.12.2. Business Overview
             16.12.3. Financial Overview
             16.12.4. Strategic Overview
             16.12.5. SWOT Analysis
     16.13. Gilead Sciences, Inc.
             16.13.1. Company Details
             16.13.2. Business Overview
             16.13.3. Financial Overview
             16.13.4. Strategic Overview
             16.13.5. SWOT Analysis

List of Tables

Table 01: Pipeline Analysis
Table 02: Global Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Type, 2017–2025
Table 03: Global Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Drug Class, 2017–2025
Table 05: Global Sterile Injectable Drugs Market Size (US$ Bn) Forecast, by Indication, 2017–2025
Table 06: Global Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Distribution Channel, 2017–2025
Table 08: Global Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Region Type, 2015–2025
Table 09: North America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, by Country, 2015–2025
Table 10: North America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Type, 2017–2025
Table 11: North America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Drug Class, 2017–2025
Table 12: North America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Indication, 2017–2025
Table 13: North America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Distribution Channel, 2017–2025
Table 14: Europe Sterile Injectable Drugs Market Size (US$ Bn) Forecast, by Country, 2015–2025
Table 15: Europe Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Type, 2017–2025
Table 16: Europe Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Drug Class, 2017–2025
Table 17: Europe Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Indication, 2017–2025
Table 18: Europe Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Distribution Channel, 2017–2025
Table 19: Asia Pacific Sterile Injectable Drugs Market Size (US$ Bn) Forecast, by Country, 2015–2025
Table 20: Asia Pacific Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Type, 2017–2025
Table 21: Asia Pacific Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Drug Class, 2017–2025
Table 22: Asia Pacific Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Indication, 2017–2025
Table 23: Asia Pacific Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Distribution Channel, 2017–2025
Table 24: Latin America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, by Country, 2015–2025
Table 25: Latin America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Type, 2017–2025
Table 26: Latin America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Drug Class, 2017–2025
Table 27: Latin America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Indication, 2017–2025
Table 28: Latin America Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Distribution Channel, 2017–2025
Table 29: Middle East & Africa Sterile Injectable Drugs Market Size (US$ Bn) Forecast, by Country, 2015–2025
Table 30: Middle East & Africa Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Type, 2017–2025
Table 31: Middle East & Africa Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Drug Class, 2017–2025
Table 32: Middle East & Africa Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Indication, 2017–2025
Table 33: Middle East & Africa Sterile Injectable Drugs Market Size (US$ Bn) Forecast, By Distribution Channel, 2017–2025

List of Figures

Figure 01: Global Sterile Injectable Drugs Market Size (US$ Bn) Forecast, 2015–2025
Figure 02: Global Sterile Injectable Drugs Market Value Share Analysis by Type, 2017 and 2025
Figure 03: Global Sterile Injectable Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Therapeutic, 2015–2025
Figure 04: Global Sterile Injectable Drugs Market Revenue (US$ Bn) and Y-o-Y Growth (%) Forecast, by Therapeutic, 2015–2025
Figure 05: Sterile Injectable Drugs Market Attractiveness Analysis by Type
Figure 06: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Monoclonal Antibodies, 2015–2025
Figure 07: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Cytokines, 2015–2025
Figure 08: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Insulin, 2015–2025
Figure 09: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Peptide Hormones, 2015–2025
Figure 10: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Vaccine, 2015–2025
Figure 11: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Immunoglobulin, 2015–2025
Figure 12: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Blood Factors, 2015–2025
Figure 13: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Peptide Antibiotics, 2015–2025
Figure 14: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Others, 2015–2025
Figure 15: Global Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Class, 2015–2025 Content
Figure 16: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Cardiology & Metabolic disorders, 2015–2025
Figure 17: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Neurology, 2015–2025
Figure 18: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Oncology, 2015–2025
Figure 19: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Autoimmune, 2015–2025
Figure 20: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Gastroenterology, 2015–2025
Figure 21: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Hematology, 2015–2025
Figure 22: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Pain, 2015–2025
Figure 23: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Infectious diseases, 2015–2025
Figure 24: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Others, 2015–2025
Figure 25: Global Sterile Injectable Drugs Market Attractiveness Analysis, by Indication, 2015–2025
Figure 26: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Hospital Pharmacy, 2015–2025
Figure 27: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by Retail Pharmacy, 2015–2025
Figure 28: Global Sterile Injectable Drugs Market Revenue (US$ Bn), by E-commerce, 2015–2025
Figure 29: Global Sterile Injectable Drugs Market Attractiveness Analysis, by Distribution Channel, 2015–2025
Figure 30: Global Sterile Injectable Drugs Market Value Share Analysis by Region Type, 2017 and 2025
Figure 31: Sterile Injectable Drugs Market Attractiveness Analysis, by Region Type
Figure 32: North America Sterile Injectable Drugs Market Size (US$ Bn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 33: North America Sterile Injectable Drugs Market Attractiveness Analysis, by Country, 2017–2025
Figure 35: North America Sterile Injectable Drugs Market Value Share Analysis, by Country, 2016 and 2025
Figure 36: North America Market Value Share Analysis by Type, 2016 and 2025
Figure 37: North America Sterile Injectable Drugs Market Value Share Analysis by Drug Class, 2016 and 2025
Figure 38: North America Sterile Injectable Drugs Market Value Share Analysis by Indication, 2016 and 2025
Figure 39: North America Sterile Injectable Drugs Market Value Share Analysis by Distribution Channel, 2016 and 2025
Figure 40: North America Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Type, 2015–2025
Figure 41: North America Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Class, 2015–2025
Figure 42: North America Sterile Injectable Drugs Market Attractiveness Analysis, by Indication, 2015–2025
Figure 43: North America Sterile Injectable Drugs Market Attractiveness Analysis, by Distribution channel, 2015–2025
Figure 44: Europe Sterile Injectable Drugs Market Size (US$ Bn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 45: Europe Sterile Injectable Drugs Market Attractiveness Analysis, by Country, 2017–2025
Figure 46: Europe Sterile Injectable Drugs Market Value Share Analysis, by Country, 2016 and 2025
Figure 47: Europe Market Value Share Analysis by Type, 2016 and 2025
Figure 48: Europe Sterile Injectable Drugs Market Value Share Analysis by Drug Class, 2016 and 2025
Figure 49: Europe Sterile Injectable Drugs Market Value Share Analysis by Indication, 2016 and 2025
Figure 50: Europe Sterile Injectable Drugs Market Value Share Analysis by Distribution Channel, 2016 and 2025
Figure 51: Europe Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Type, 2015–2025
Figure 52: Europe Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Class, 2015–2025
Figure 53: Europe Sterile Injectable Drugs Market Attractiveness Analysis, by Indication, 2015–2025
Figure 54: Europe Sterile Injectable Drugs Market Attractiveness Analysis, by Distribution channel, 2015–2025
Figure 55: Asia Pacific Sterile Injectable Drugs Market Size (US$ Bn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 56: Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, by Country, 2017–2025
Figure 57: Asia Pacific Sterile Injectable Drugs Market Value Share Analysis, by Country, 2016 and 2025
Figure 58: Asia Pacific Market Value Share Analysis by Type, 2016 and 2025
Figure 59: Asia Pacific Sterile Injectable Drugs Market Value Share Analysis by Drug Class, 2016 and 2025
Figure 60: Asia Pacific Sterile Injectable Drugs Market Value Share Analysis by Indication, 2016 and 2025
Figure 61: Asia Pacific Sterile Injectable Drugs Market Value Share Analysis by Distribution Channel, 2016 and 2025
Figure 62: Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Type, 2015–2025
Figure 63: Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Class, 2015–2025
Figure 64: Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, by Indication, 2015–2025
Figure 65: Asia Pacific Sterile Injectable Drugs Market Attractiveness Analysis, by Distribution channel, 2015–2025
Figure 66: Latin America Sterile Injectable Drugs Market Size (US$ Bn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 67: Latin America Sterile Injectable Drugs Market Attractiveness Analysis, by Country, 2017–2025
Figure 68: Latin America Sterile Injectable Drugs Market Value Share Analysis, by Country, 2016 and 2025
Figure 69: Latin America Market Value Share Analysis by Type, 2016 and 2025
Figure 70: Latin America Sterile Injectable Drugs Market Value Share Analysis by Drug Class, 2016 and 2025
Figure 71: Latin America Sterile Injectable Drugs Market Value Share Analysis by Indication, 2016 and 2025
Figure 72: Latin America Sterile Injectable Drugs Market Value Share Analysis by Distribution Channel, 2016 and 2025
Figure 73: Latin America Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Type, 2015–2025
Figure 74: Latin America Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Class, 2015–2025
Figure 75: Latin America Sterile Injectable Drugs Market Attractiveness Analysis, by Indication, 2015–2025
Figure 76: Latin America Sterile Injectable Drugs Market Attractiveness Analysis, by Distribution channel, 2015–2025
Figure 77: Middle East & Africa Sterile Injectable Drugs Market Size (US$ Bn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 78: Middle East & Africa Sterile Injectable Drugs Market Attractiveness Analysis, by Country, 2017–2025
Figure 79: Middle East & Africa Sterile Injectable Drugs Market Value Share Analysis, by Country, 2016 and 2025
Figure 80: Middle East & Africa Market Value Share Analysis by Type, 2016 and 2025
Figure 81: Middle East & Africa Sterile Injectable Drugs Market Value Share Analysis by Drug Class, 2016 and 2025
Figure 82: Middle East & Africa Sterile Injectable Drugs Market Value Share Analysis by Indication, 2016 and 2025
Figure 83: Middle East & Africa Sterile Injectable Drugs Market Value Share Analysis by Distribution Channel, 2016 and 2025
Figure 84: Middle East & Africa Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Type, 2015–2025
Figure 85: Middle East & Africa Sterile Injectable Drugs Market Attractiveness Analysis, by Drug Class, 2015–2025
Figure 86: Middle East & Africa Sterile Injectable Drugs Market Attractiveness Analysis, by Indication, 2015–2025
Figure 87: Middle East & Africa Sterile Injectable Drugs Market Attractiveness Analysis, by Distribution channel, 2015–2025
Figure 88: Heat Map Analysis by Company (2016)

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Sterile Injectable Drugs Market